To investigate the efficacy of the intake of vinegar for prevention of hyperlipidaemia, we examined the effect of dietary acetic acid, the main component of vinegar, on serum lipid values in rats fed a diet containing 1 % (w/w) cholesterol. Animals were allowed free access to a diet containing no cholesterol, a diet containing 1 % cholesterol without acetic acid, or a diet containing 1 % cholesterol with 0·3 % (w/w) acetic acid for 19 d. Then, they were killed after food deprivation for 7 h. Cholesterol feeding increased serum total cholesterol and triacylglycerol levels. Compared with the cholesterol-fed group, the cholesterol and acetic acid-fed group had significantly lower values for serum total cholesterol and triacylglycerols, liver ATP citrate lyase (ATP-CL) activity, and liver 3-hydroxy-3-methylglutaryl-CoA content as well as liver mRNA levels of sterol regulatory element binding protein-1, ATP-CL and fatty acid synthase (P, 0·05). Further, the serum secretin level, liver acyl-CoA oxidase expression, and faecal bile acid content were significantly higher in the cholesterol and acetic acid-fed group than in the cholesterol-fed group (P, 0·05). However, acetic acid feeding affected neither the mRNA level nor activity of cholesterol 7a-hydroxylase. In conclusion, dietary acetic acid reduced serum total cholesterol and triacylglycerol: first due to the inhibition of lipogenesis in liver; second due to the increment in faecal bile acid excretion in rats fed a diet containing cholesterol.
Acetic acid is a main component of vinegar at a concentration of 3-9 % for consumer use (Ren et al. 1997) . Vinegar is not only used commonly as a condiment but also traditionally as a folk medicine (Ross & Poluhowich, 1984; Nakazawa & Muraoka, 1989) . In animal studies, we showed previously that a diet containing acetic acid or vinegar at concentrations found in traditional diets has such effects as enhancement of glycogen repletion (Fushimi et al. 2001 (Fushimi et al. , 2002 , prevention of hypertension (Kondo et al. 2001) and stimulation of Ca absorption (Kishi et al. 1999) . However, very little is known about the effect of dietary acetic acid on lipid metabolism.
Acetic acid is one of the SCFA, which are products of the caecal and colonic fermentation that is stimulated by the ingestion of dietary fibre. Feeding highly fermentable dietary fibre is reported to reduce the increments of serum cholesterol (Aritsuka et al. 1989) . Previously, Hara et al. (1999) reported that a fibre-free diet containing SCFA decreases serum cholesterol. However, the diet used in that study contained 3·5 % sodium acetate as an Na salt, which is excessive in comparison with foods prepared with vinegar, such as sushi containing 0·2 -0·6 % acetic acid (Mine et al. 1982; Fujii et al. 1992; Chang et al. 1994) .
Absorbed acetic acid is taken up and then metabolised via acetyl-CoA in the tricarboxylic acid cycle in the liver and peripheral tissues (Ballard, 1972; Spydevold et al. 1976; Crabtree et al. 1990) . Thus, acetate has been utilised as a substrate of lipogenesis in many cell studies. On the other hand, when acetate is metabolised by acetyl-CoA synthetase, AMP is simultaneously produced: acetate þ CoA þ ATP $ acetyl-CoA þ AMP þ pyrophosphate. Based on this point, Kawaguchi et al. (2002) reported that in hepatocytes acetate activated AMP-activated protein kinase (AMPK), the inhibitor of fatty acid and sterol synthesis (for reviews, see Hardie et al. 1998; Winder & Hardie, 1999; Hardie, 2003) . We very recently reported that dietary acetic acid reduced the increment of malonyl-CoA content in liver of rats under postprandial conditions (Fushimi & Sato, 2005) . Since in a review article it was pointed out that malonyl-CoA content was down regulated by the activation of AMPK (Saha & Ruderman, 2003) , it could be supposed that dietary acetic acid may influence lipid synthesis in rats.
Considering these findings, it remains unclear whether a diet containing acetic acid at a concentration found in traditional diets affects lipid metabolism. In the present study, we explored the efficacy of vinegar for prevention of hyperlipidaemia and examined whether a diet containing 0·3 % acetic acid, a concentration corresponding to that in sushi, a traditional Japanese food (Mine et al. 1982; Fujii et al. 1992; Chang et al. 1994) , would affect lipid metabolism in rats fed a cholesterol-rich diet.
Materials and methods

Animals, feeding protocol and diets
Male rats aged 5 weeks (Sprague -Dawley; Japan SLC, Hamamatsu, Japan) weighing 145 (SEM 1) g were individually housed in a temperature-controlled room (23-258C) with a 12 h light-dark cycle. The light period began from 07.00 hours. The animals had free access to water and a powdered AIN-93G (Reeves et al. 1993 ) purified diet (Oriental Yeast Co., Ltd, Tokyo, Japan) for 9 d. On the 8th day of the acclimatisation period food was withdrawn at 08.00 hours. After a 7 h period of food deprivation, blood was collected from the retroorbital plexus of the rats under anaesthesia with diethyl ether. On the next day (defined as day 0 of the experimental period), serum cholesterol, triacylglycerol and NEFA values were measured by a clinical automatic analyser (Automatic analyser 736-10; Hitachi, Tokyo, Japan). On the 1st day of the experimental period, the animals were divided into three groups of eight, each with a similar mean body weight (184 (SEM 2) g) and a similar mean concentration of serum total cholesterol (855 (SEM 30) mg/l), triacylglycerols (551 (SEM 31) mg/l) and NEFA (0·73 (SEM 0·04) mmol/l). The rats were cared for in accordance with the Guidelines for Animal Experimentation at the 34th Annual Meeting of the Japanese Association for Laboratory Animal Science, held 22 May 1987.
From the 1st day of the experimental period, each group was given one of three experimental diets for the 19 d experimental period (Table 1) . The experimental diets, based on the powdered AIN-93G diet, contained no cholesterol (no-cholesterol diet), 1 % cholesterol without acetic acid (cholesterol diet), or 1 % cholesterol and 0·3 % acetic acid (cholesterol and acetic acid diet). Food intake on day 7 and day 14 and body weight on day 9 and day 16 were measured. On day 13, of the experimental period, rats were removed to a metabolism cage for 48 h, and faeces were collected during that period. On day 20, food was withdrawn at 07.00 hours. After a 7 h period of food deprivation, whole blood was drawn from the abdominal aorta under anaesthesia with diethyl ether. Livers were dissected quickly and a portion was treated for the measurement of enzyme activities; the remaining portion was immediately submerged and powdered in liquid N 2 . Serum and powdered liver were stored at 2808C until assay.
Measurements of serum metabolites and hormones
Serum total cholesterol and triacylglycerols were measured by an automatic analyser system as described earlier. Serum insulin, glucagon, glucagon-like peptide 1, cholecystokinin and secretin were assayed by ELISA kits (ultra sensitive rat insulin ELISA kit (Morinaga Bioscience, Kanagawa, Japan); rat glucagon ELISA kit Wako (Wako Pure Chemicals, Osaka, Japan); glucagon-like peptide 1 EIA kit (Yanaihara, Fujinomiya, Japan); cholecystokinin 26 -33 EIA kit and secretin EIA kit (Phoenix Pharmaceuticals, Inc., Belmont, CA, USA)).
Ribonucleic acid isolation and Northern blotting
Total RNA from rat liver was extracted using TRI reagent (Molecular Research Center, Inc., Cincinnati, OH, USA) according to the supplier's isolation procedures. Northern blot analysis was performed using 32 P-labelled cDNA probes as described previously (Goda et al. 1994) . The cDNA probes used in the Northern blot analysis were generated by the reverse-transcription PCR method as follows: rat liver X receptor type a, a fragment corresponding to þ1 to þ1562 (Apfel et al. 1994) ; rat cholesterol 7a-hydroxylase (CYP7A1), a fragment corresponding to þ49 to þ1009 (Noshiro et al. 1989) ; rat acyl-CoA oxidase (AOX), a fragment corresponding to þ131 to þ591 (GenBank accession no. J02752) (Mochizuki et al. 2001) ; mouse sterol regulatory element binding protein-1 (SREBP-1), a fragment corresponding to þ169 to þ1196 (GenBank accession no. NM011480); rat glyceraldehyde phosphate dehydrogenase (GAPDH), a fragment corresponding to þ1087 to þ1407 (GenBank accession no. NM017008) (Mochizuki et al. 2002) . Specific mRNA signals were scanned using STORM (Amersham Pharmacia Biotech, Tokyo, Japan) and signal densities were standardised for the corresponding GAPDH mRNA levels. 
Semi-quantitative reverse transcriptase polymerase chain reaction
The relative abundances of lipogenic mRNA (ATP citrate lyase (ATP-CL), fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC)) were determined by a semi-quantitative RT-PCR method. Total RNA from rat liver was extracted as described earlier and reverse transcription was performed by incubating 1 mg total RNA, random hexamers (2·5 mmol/l; Takara Bio. Co., Kyoto, Japan), the four deoxyribonucleotide triphosphates (each 0·5 mmol/l), 1X reaction buffer, 10 U RNasin (TOYOBO Co., Osaka, Japan), and 4 U Omniscript RT (Qiagen, Tokyo, Japan) in a final volume of 20 ml at 378C for 1 h. The PCR were then done in a 12·5 ml reaction volume containing 1 ml cDNA, the four deoxyribonucleotide triphosphates (each 0·2 mmol/l), 1X Ex-Taq reaction buffer, the appropriate oligonucleotide primers (0·5 mmol/l; Table 2 ) and 0·5 U Takara EX-Taq DNA polymerase (Takara Bio. Co., Kyoto, Japan). The number of cycles was selected to allow linear amplification of the cDNA. All PCR reactions used a hot-start procedure (incubation at 948C for 2 min), denaturation at 948C for 30 s, annealing at an appropriate temperature (see Table 2 ) for 30 s, extension at 728C for 30 s and final incubation at 728C for 5 min. PCR products were electrophoresed on 1 % agarose-tri(hydroxymethyl)-aminomethane-borate EDTA gels, stained with ethidium bromide, and analysed on a Fluoro Imager (Molecular Dynamics, Grefeld, Germany). mRNA abundance was expressed as band intensity relative to the corresponding 18S rRNA band intensity.
Determinations of liver metabolites and enzyme activity
Lipids in liver were extracted from freeze-stored liver by Folch's method (Folch et al. 1957) , and extracted cholesterol and triacylglycerols were measured by individual assay kits (cholesterol C-test Wako and triglyceride E-test Wako, respectively; Wako Pure Chemicals, Osaka, Japan). 3-Hydroxy-3-methylglutaryl-CoA (HMG-CoA) was determined by a previously reported HPLC method (DeBuysere & Olson, 1983 ) with a slight modification. In brief, mobilephase solvents were A (sodium phosphate (0·2 mol/l), 1 % chloroform (v/v), pH 5·0) and B (sodium phosphate (0·2 mol/l), 49 % methanol, 1 % chloroform (v/v), pH 5·0).
The percentage of solvent B was 12 at time 0, 16 at 8 min, 26 at 14 min, 40 at 20 min, and 90 at 32 min, rising in a linear manner. After the final composition of solvent B reached 90 %, it was held for 3 min and the initial condition was re-established for 10 min in a linear manner. This composition was kept for 10 min additionally, and the column was then ready for the next injection. ATP-CL and CYP7A1 activities were measured as previously described (Takeda et al. 1969; Yokogoshi et al. 1999, respectively) .
Measurements of faecal neutral steroids and bile acids
Faecal neutral steroids and acid steroids were extracted from collected faeces as described previously (Moundras et al. 1997) 
Results
Body weight and food intake
There were no significant differences in either body weight or food intake among the three groups (Table 3) .
Serum lipids
In the cholesterol diet group, serum total cholesterol and triacylglycerol concentrations were significantly higher than in the no-cholesterol group (Table 4) . The cholesterol and acetic acid diet group had a significantly higher serum total cholesterol level than the no-cholesterol diet group, but serum triacylglycerol levels did not differ significantly between the two groups. Further, the cholesterol and acetic acid diet group had significantly lower serum total cholesterol and triacylglycerol concentrations than the cholesterol diet group.
Serum hormones
Serum insulin levels did not differ significantly between the no-cholesterol diet group and the cholesterol diet group. In the cholesterol and acetic acid diet group, the mean serum insulin level was significantly lower (P, 0·05) than in the no-cholesterol diet group, and tended to be lower (P, 0·1) than in the cholesterol diet group (Table 4) . The serum secretin level was significantly higher in the cholesterol and acetic acid diet group than in the other two groups. There were no significant differences in the concentrations of glucagon, glucagon-like peptide 1 or cholecystokinin among the groups (data not shown).
Gene expressions in the liver
To examine whether gene expressions of lipogenic enzymes are affected by dietary acetic acid, transcript levels of SREBP-1, a transcription factor involved in regulation of lipogenesis, and ATP-CL, FAS and ACC were measured in the liver. As shown in Fig. 1 , the cholesterol diet group had significantly greater SREBP-1 mRNA levels in the liver than the no-cholesterol diet group. However, in the cholesterol and acetic acid diet group, SREBP-1 mRNA levels in the liver were significantly lower than in the cholesterol diet group. The SREBP-1 mRNA levels in the cholesterol and acetic acid diet group did not differ significantly from those in the no-cholesterol diet group. Whereas no significant differences were observed in mRNA levels of ATP-CL or FAS between the no-cholesterol and cholesterol diet groups, the cholesterol and acetic acid diet group had significantly lower ATP-CL and FAS mRNA levels in the liver than did the other two groups. The transcript levels of ACC in the liver of the no-cholesterol diet group were significantly higher than in the other two diet groups. In addition, the cholesterol and acetic acid diet group tended to have lower mRNA levels of ACC than the cholesterol diet group (P, 0·1) (Fig. 1) .
To examine whether b-oxidation of fatty acids and/or cholesterol metabolism in the liver was influenced by dietary acetic acid, we next determined the transcript levels of AOX, CYP7A1, a rate-limiting enzyme producing bile acid, and liver X receptor a, a nuclear receptor known to play a pivotal role in cholesterol homeostasis in hepatic cells. As shown in Fig. 2 , the AOX mRNA level in the cholesterol and acetic acid diet group was significantly greater than in the other groups. The CYP7A1 mRNA levels in both the cholesterol diet group and the cholesterol and acetic acid diet group were significantly greater than in the no-cholesterol diet group; these levels, however, did not differ significantly between the cholesterol diet and cholesterol and acetic acid diet groups. There was no significant difference in the expression of liver X receptor a mRNA among the groups.
Metabolites and enzyme activity in liver
The concentrations of cholesterol, triacylglycerols and HMGCoA and the ATP-CL activity in the liver are summarised in Table 5 . Feeding a cholesterol-rich diet caused significantly elevated cholesterol and triacylglycerol concentrations in the liver compared with feeding of the no-cholesterol diet. In the cholesterol and acetic acid diet group, the hepatic concentrations of both cholesterol and triacylglycerols Tables 1 and 3 . Serum was collected from the abdominal aorta after a 7 h period of food deprivation on day 20 of the experimental period (see p. 917). † Mean value was significantly different from that of the no-cholesterol group (P, 0·05). ‡ Mean value was significantly different from that of the cholesterol group (P, 0·05). * Rats were fed an experimental diet for 19 d and grouped according to a diet containing either no cholesterol without acetic acid (no-cholesterol group), 1 % cholesterol without acetic acid (cholesterol group), or 1 % cholesterol with 0·3 % acetic acid (cholesterol and acetic acid group). † Body weight was measured on day 1, day 9 and day 16 of the experimental period (see p. 917). ‡ Food intake was measured on day 7 and day 14 of the experimental period (see p. 917).
tended to be lower than in the cholesterol diet group (P,0·1). Although there was no difference in HMG-CoA concentration in the liver between the no-cholesterol diet and cholesterol diet groups, this value was significantly lower in the cholesterol and acetic acid diet group. Similarly, there were no significant differences in ATP-CL activity in the liver between the no-cholesterol diet and cholesterol diet groups, but such activity was significantly lower in the cholesterol and acetic acid diet group than in the other groups. With regard to CYP7A1 activities, differences were not significant among the three groups; neither were mRNA levels.
Faecal steroids
Faecal neutral steroid excretion was similarly elevated in both the cholesterol and cholesterol and acetic acid diet groups compared with the no-cholesterol diet group. However, no significant difference was observed between the cholesterol and cholesterol and acetic acid diet groups (Table 5 ). Faecal bile acid excretion in the cholesterol diet group was 3·5 times as great as that in the no-cholesterol diet group. Excretion of bile acid in the faeces was slightly but significantly greater in the cholesterol and acetic acid diet group than the cholesterol diet group (Table 5) .
Discussion
In the present study, we demonstrated that dietary acetic acid reduces serum concentrations of total cholesterol and triacylglycerols in rats fed a cholesterol-rich diet, with a tendency for a reduction of cholesterol and triacylglycerol concentrations in the liver. Dietary cholesterol has been reported to stimulate hepatic triacylglycerol biosynthesis by reduction of fatty acid oxidation, leading to an increase in plasma triacylglycerol concentration (Fungwe et al. 1993 (Fungwe et al. , 1994 . In the present study, we found that AOX gene expression was elevated in the cholesterol and acetic acid diet group, suggesting that dietary acetic acid might attenuate the cholesterol-mediated increase in hepatic triacylglycerol synthesis and eventually suppress the elevation of serum triacylglycerol concentrations.
We also found that the mRNA level of SREBP-1, a nuclear factor known to play a pivotal role in the regulation of fatty acid synthesis in the liver (Foufelle & Ferré, 2002) , was significantly reduced by dietary acetic acid in rats fed a cholesterol-rich diet. Indeed, mRNA levels of ATP-CL, FAS and ACC, which are related to fatty acid synthesis and regulated transcriptionally (Sato et al. 2000; Bennett et al. 1995; Lopez et al. 1996, respectively) , were reduced in the cholesterol and acetic acid diet group. The cholesterol diet group had a significantly higher SREBP-1 mRNA level than the no-cholesterol diet group. However, mRNA levels of SREBP-1-responsive genes for ATP-CL, FAS and ACC in the cholesterol diet group were generally lower than those in the no-cholesterol diet group. Cholesterol has been reported to reduce mRNA levels of ATP-CL, FAS and ACC in hepatocytes (Sato et al. 2000; Bennett et al. 1995; Lopez et al. 1996, respectively) . Thus, it is not unexpected that these mRNA levels in the cholesterol diet group were lower than those in the no-cholesterol diet group. Further, the cholesterol and acetic acid group had lower mRNA levels than the cholesterol group, which had lower mRNA levels than the no-cholesterol group, because the cholesterol and acetic acid diet group had significantly lower SREBP-1 mRNA levels than the cholesterol diet group. Therefore, it is very likely that dietary acetic acid inhibits fatty acid synthesis through a decrease in SREBP-1 mRNA. Indeed, it should be noted that the activity of ATP-CL, which plays an important role in supplying acetyl-CoA to pathways of both cholesterogenesis and lipogenesis (Pearce et al. 1998) , was markedly reduced in the cholesterol and acetic acid diet group.
Further, the hepatic concentration of HMG-CoA, a main substrate for cholesterol synthesis, was reduced by dietary acetic acid. Since HMG-CoA is a metabolite on the cholesterol synthesis pathway from acetyl-CoA, the lower HMGCoA content in the cholesterol and acetic acid diet group might result from the reduction of both the mRNA level and activity of ATP-CL by acetic acid feeding. HMG-CoA synthesis is catalysed by HMG-CoA synthase. While the transcription of this enzyme is regulated by SREBP-1a or -2 (Horton et al. 1998) , it has been reported that cholesterol reduced the mRNA level of HMG-CoA synthase in hepatocytes (Bennett et al. 1995; Lopez et al. 1996) . Therefore, the HMG-CoA content in the cholesterol diet group was about 90 % of that in the no-cholesterol diet group, a difference that was without significance, although the cholesterol diet group had a significantly higher SREBP-1 mRNA level than the no-cholesterol diet group.
Taken together, these results suggest that dietary acetic acid may reduce the supply of acetyl-CoA, as a common substrate for cholesterol and fatty acid synthesis, through the reduction of both the mRNA level and activity of ATP-CL caused by the suppression of SREBP-1 gene expression. We also found that dietary acetic acid caused an increase in AOX gene expression, which indicates elevated fatty acid b-oxidation. Thus, it seems likely that dietary acetic acid affects not only fatty acid synthesis and cholesterol synthesis in the liver, but also fatty acid oxidation, leading eventually to reduction of serum cholesterol and triacylglycerol concentrations.
It is well known that through SREBP-1, insulin up regulates the expression of lipogenic genes, including ATP-CL, FAS and ACC (Foufelle & Ferré, 2002) . The present results showed that the serum insulin level was reduced in the cholesterol and acetic acid diet group. In a study on human subjects, intake of a starchy meal with vinegar was reported to lead to suppression of postprandial increments in serum glucose and insulin by a delayed gastric emptying rate (Liljeberg & Björck, 1998) . Hence, continuous acetic acid feeding may lead to a chronically lowered serum insulin value. On the other hand, it was recently reported that AMPK was activated Tables 1 and 3 . Liver was dissected after a 7 h period of food deprivation on day 20, and faeces were collected on day 15 of the experimental period (see p. 917). † Mean value was significantly different from that of the no-cholesterol group (P,0·05). ‡ Mean value was significantly different from that of the cholesterol group (P, 0·05).
in hepatocytes cultured in the presence of acetate (Kawaguchi et al. 2002) . The activation of AMPK has been shown to repress the hepatic SREBP-1 mRNA level and the amount of the mature form of SREBP-1 protein in nuclei, concomitant with reduced expressions of lipogenic genes including FAS and ACC (Zhou et al. 2001) , as well as lowered fatty acid synthesis and cholesterol synthesis (for reviews, see Hardie et al. 1998; Winder & Hardie, 1999; Hardie, 2003) . Although the present study had no data on the amount of the mature form of SREBP-1 protein in nuclei, we found that acetic acid feeding reduced mRNA levels of SREBP-1 responsive genes (ATP-CL, FAS and ACC) as well as that of SREBP-1. In consideration of these factors, we speculate that the suppression of SREBP-1 mRNA expression observed in the liver of rats fed the cholesterol and acetic acid diet is attributable to a lowering of serum insulin levels and/or an acetic acid-mediated activation of AMPK.
In the present study, we showed that faecal bile acid excretion was enhanced by dietary acetic acid in rats fed a cholesterol-rich diet. Although both the level of CYP7A1 mRNA and its activity were unaffected by dietary acetic acid, it is likely that bile acid secretion from the liver may be enhanced in the cholesterol and acetic acid diet group, because this group had a significantly higher serum secretin concentration than the cholesterol diet group. Previous reports showed that secretin enhances the release of bile acid in hepatocytes (Shimizu et al. 1987) , and that intraduodenal perfusion of acetic acid at a higher concentration than physiological levels was accompanied by secretin release (Sanchez-Vincente et al. 1995) . Thus, it could be assumed that acetic acid feeding promotes bile acid excretion through the stimulation of secretin release. However, there is no report about the correlation between serum secretin levels and faecal bile acid content in vivo. In order to confirm this interpretation, it should be made clear whether secretin directly increases faecal bile acid excretion in vivo, and whether dietary acetic acid directly stimulates secretin release at physiological concentrations.
In summary, the present results suggest that dietary acetic acid reduces serum cholesterol and triacylglycerol concentrations in rats fed a cholesterol-rich diet through inhibition of metabolic pathways of cholesterogenesis and lipogenesis in the liver, together with a concomitant enhancement of fatty acid oxidation and a stimulation of faecal bile acid excretion. In future, it is important to confirm the same effect of dietary acetic acid on lipid metabolism in human subjects. Thus, hamsters should be studied at the next stage of this investigation, as their lipid metabolism is closer to that of man than lipid metabolism in the rat.
